- Home
- ARMP vs WPAC Comparison
ARMP vs WPAC Comparison
Compare ARMP & WPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARMP | WPAC |
|---|---|---|
| Founded | N/A | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 156.4M | 157.0M |
| IPO Year | 1996 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ARMP | WPAC |
|---|---|---|
| Price | $4.40 | $10.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 95.5K | 11.6K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.40 | $9.82 |
| 52 Week High | $14.98 | $11.89 |
Technical Indicators
Market Signals| Indicator | ARMP | WPAC |
|---|---|---|
| Relative Strength Index (RSI) | 44.18 | 53.58 |
| Support Level | $4.36 | $9.96 |
| Resistance Level | $5.60 | $10.11 |
| Average True Range (ATR) | 0.52 | 0.01 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 27.38 | 71.43 |
Price Performance
Historical ComparisonAbout ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
About WPAC White Pearl Acquisition Corp. Class A Ordinary Shares
White Pearl Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.